
Health Minister Kwabena Mintah Akandoh has announced that the Ghanaian government is currently reviewing a revised health financing memorandum of understanding (MoU) from the United States. This follows the government’s earlier decision to reject an initial proposal that was deemed incompatible with national interests. The new document is being scrutinised to ensure it aligns with Ghana's legal framework and regulatory standards before any final determination is made by the Cabinet. The initial proposal from the US was turned down due to significant concerns regarding national sovereignty and regulatory authority. Specifically, the Ghanaian government took issue with provisions that would have granted US pharmaceutical companies exemptions from local verification processes and data-sharing requirements. Minister Akandoh noted that these terms were unacceptable as they would have bypassed established Ghanaian protocols and regulatory oversight. Emphasizing the government’s position, Akandoh stated that international partnerships must be built on a foundation of dignity and mutual respect. He maintained that no agreement would be signed if it compromised the country’s laws or the authority of its regulatory bodies. The Minister confirmed that the government has documented its specific concerns regarding the previous draft to guide the evaluation of the current proposal. The revised MoU is now being prepared for Cabinet review. Akandoh clarified that while the government remains open to collaboration, no final decision will be reached until the Cabinet has thoroughly considered the updated terms. This review process reflects the administration's broader commitment to protecting domestic industries and maintaining independent regulatory standards within the national health sector.